Cargando…

Pharmacological treatment patterns in patients with juvenile idiopathic arthritis in the Netherlands: a real-world data analysis

OBJECTIVE: To investigate medication prescription patterns among children with JIA, including duration, sequence and reasons for medication discontinuation. METHODS: This study is a single-centre, retrospective analysis of prospective data from the electronic medical records of JIA patients receivin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kip, Michelle M A, de Roock, Sytze, Currie, Gillian, Marshall, Deborah A, Grazziotin, Luiza R, Twilt, Marinka, Yeung, Rae S M, Benseler, Susanne M, Vastert, Sebastiaan J, Wulffraat, Nico, Swart, Joost F, IJzerman, Maarten J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9949706/ https://www.ncbi.nlm.nih.gov/pubmed/35583252 http://dx.doi.org/10.1093/rheumatology/keac299

Ejemplares similares

Costs of Hospital‐Associated Care for Patients With Juvenile Idiopathic Arthritis in the Dutch Health Care System
por: Kip, Michelle M. A., et al.
Publicado: (2022)

Seeking the state of the art in standardized measurement of health care resource use and costs in juvenile idiopathic arthritis: a scoping review
por: Kip, Michelle M. A., et al.
Publicado: (2019)

Real-world data reveals the complexity of disease modifying anti-rheumatic drug treatment patterns in juvenile idiopathic arthritis: an observational study
por: Grazziotin, Luiza R., et al.
Publicado: (2022)

Factors associated with care- and health-related quality of life of caregivers of children with juvenile idiopathic arthritis
por: Grazziotin, Luiza R., et al.
Publicado: (2022)

Evaluation of Real-World Healthcare Resource Utilization and Associated Costs in Children with Juvenile Idiopathic Arthritis: A Canadian Retrospective Cohort Study
por: Grazziotin, Luiza R., et al.
Publicado: (2021)

Genomic Health Literacy Interventions in Pediatrics: Scoping Review
por: Gupta, Aarushi, et al.
Publicado: (2021)

Withdrawing biologics in non-systemic JIA: what matters to pediatric rheumatologists?
por: van Til, Janine A., et al.
Publicado: (2023)

What are the immunological consequences of long-term use of biological therapies for juvenile idiopathic arthritis?
por: Swart, Joost F, et al.
Publicado: (2013)

Clinical Juvenile Arthritis Disease Activity Score proves to be a useful tool in treat-to-target therapy in juvenile idiopathic arthritis
por: Swart, Joost F, et al.
Publicado: (2018)

The human microbiome and juvenile idiopathic arthritis
por: Verwoerd, Anouk, et al.
Publicado: (2016)

Bone-marrow derived mesenchymal stromal cells infusion in therapy refractory juvenile idiopathic arthritis patients
por: Swart, Joost F, et al.
Publicado: (2019)

Monitoring patients with juvenile idiopathic arthritis using health-related quality of life
por: Doeleman, Martijn J. H., et al.
Publicado: (2021)

Methotrexate therapy associated with a reduced rate of new-onset uveitis in patients with biological-naïve juvenile idiopathic arthritis
por: van Straalen, Joeri W, et al.
Publicado: (2023)

PReS-FINAL-2147: Immunological consequences of biologicals in juvenile idiopathic arthritis
por: Swart, JF, et al.
Publicado: (2013)

Evaluating key performance indicators of the process of care in juvenile idiopathic arthritis
por: Cooper, Sarah M., et al.
Publicado: (2023)

The Dutch version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)
por: Wulffraat, Nico, et al.
Publicado: (2018)

Prevalence of familial autoimmune diseases in juvenile idiopathic arthritis: results from the international Pharmachild registry
por: van Straalen, Joeri W., et al.
Publicado: (2022)

Treatment to Target Using Recombinant Interleukin‐1 Receptor Antagonist as First‐Line Monotherapy in New‐Onset Systemic Juvenile Idiopathic Arthritis: Results From a Five‐Year Follow‐Up Study
por: ter Haar, Nienke M., et al.
Publicado: (2019)

Methotrexate restores effector T cell responsiveness in juvenile idiopathic arthritis
por: Bulatović, Maja, et al.
Publicado: (2011)

Immunomodulatory actions of methotrexate on T cells in juvenile idiopathic arthritis
por: Ćalasan, Maja Bulatović, et al.
Publicado: (2012)

Treating juvenile idiopathic arthritis to target: what is the optimal target definition to reach all goals?
por: Schoemaker, Casper G., et al.
Publicado: (2020)

Juvenile idiopathic arthritis patients with positive family history of autoimmune thyroid disease might benefit from serological screening: analysis of the international Pharmachild registry
por: van Straalen, Joeri W., et al.
Publicado: (2023)

PReS-FINAL-2107: In vitro investigation into mesenchymal stromal cells as a potential therapeutic in juvenile arthritis
por: Wienke, J, et al.
Publicado: (2013)

Mesenchymal stromal cells suppress synovial fluid-derived t cells from juvenile idiopathic arthritis patients in vitro
por: Wienke, J, et al.
Publicado: (2014)

Real-world comparison of the effects of etanercept and adalimumab on well-being in non-systemic juvenile idiopathic arthritis: a propensity score matched cohort study
por: van Straalen, Joeri W., et al.
Publicado: (2022)

The role of etanercept in juvenile dermatomyositis (JDMS) in children
por: Green, Katherine L, et al.
Publicado: (2014)

Juvenile Arthritis Patients Suffering from Chronic Inflammation Have Increased Activity of Both IDO and GTP-CH1 Pathways But Decreased BH4 Efficacy: Implications for Well-Being, Including Fatigue, Cognitive Impairment, Anxiety, and Depression
por: Korte-Bouws, Gerdien A. H., et al.
Publicado: (2019)

The growing spectrum of antibody-associated inflammatory brain diseases in children
por: Bigi, Sandra, et al.
Publicado: (2015)

Strategies for treatment of childhood primary angiitis of the central nervous system
por: Beelen, Jocelyne, et al.
Publicado: (2019)

A clinical prediction model for estimating the risk of developing uveitis in patients with juvenile idiopathic arthritis
por: van Straalen, Joeri W, et al.
Publicado: (2020)

Comparison of CNS vasculitis in children and adults; is this the same disease entity
por: Twilt, Marinka, et al.
Publicado: (2011)

Burden of comorbid conditions in children and young people with juvenile idiopathic arthritis: a collaborative analysis of 3 JIA registries
por: Kearsley-Fleet, Lianne, et al.
Publicado: (2021)

Comparison of CNS vasculitis in children and adults; is this the same disease entity
por: Twilt, Marinka, et al.
Publicado: (2012)

Serum biomarkers confirming stable remission in inflammatory bowel disease
por: Kessel, Christoph, et al.
Publicado: (2021)

Evaluation of an nhs juvenile idiopathic arthritis (JIA) treatment pathway compared to published international recommendations
por: Green, Katherone L, et al.
Publicado: (2014)

Time to share
por: Wulffraat, Nico M, et al.
Publicado: (2013)

Prediction of Methotrexate Intolerance in Juvenile Idiopathic Arthritis: a prospective, observational cohort study
por: van Dijkhuizen, Evert Hendrik Pieter, et al.
Publicado: (2015)

Childhood Takayasu arteritis: disease course and response to therapy
por: Aeschlimann, Florence A., et al.
Publicado: (2017)

Patient factors associated with waiting time to pediatric rheumatologist consultation for patients with juvenile idiopathic arthritis
por: Barber, Claire E. H., et al.
Publicado: (2020)

Patient’s experiences with the care for juvenile idiopathic arthritis across Europe
por: van Dijkhuizen, E. H. Pieter., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ljt7snv5v4si6s06mafcqc2f75